InMed Pharmaceuticals
INM----
Q3 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: InMed Pharmaceuticals(INM) the EBIT is -2.816 M (-36.62%);the EPS is -0.733 (+62.14%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B36.62%
----
----
EPS
-0.732862.14%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf